Association between sleep duration, sleep trouble and all-cause mortality in individuals with hyperuricemia in the United States
Frontiers in Public Health · 2025
DOI: 10.3389/fpubh.2025.1521372 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, 2025. Verfasst von Yuanhui Dai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China. Hauptthemen laut MEDLINE: Hyperuricemia, Sleep Wake Disorders, Sleep, Mortality. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Despite the crucial role of sleep quality in hyperuricemia onset and progression, there is limited evidence on sleep interventions to improve outcomes for hyperuricemic individuals. This study aims to investigate the effects of sleep duration and sleep difficulties on all-cause mortality in this population. Materials and methods We conducted a secondary analysis of the National Health and Nutrition Examination Survey (NHANES) data from 2007 to 2018, including 5,837 participants. We employed weighted multivariable Cox proportional hazard models to evaluate the independent predictive value of sleep duration and trouble for all-cause mortality. Restricted cubic splines and segmented Cox proportional hazard models were used to examine threshold effects.
Results
During a mean follow-up of 6.5 years, 906 participants experienced all-cause mortality. After adjusting for confounders, both short (< 7 h; HR = 1.25; 95%CI: 1.04, 1.51; p = 0.018) and long (>9 h; HR = 1.50; 95%CI: 1.10, 2.04; p = 0.011) sleep durations were associated with increased all-cause mortality. The threshold analysis identified an optimal sleep duration of 7.23 h, and when sleep duration was below 7.23 h, it was inversely related to mortality (HR: 0.879; 95% CI: 0.788, 0.981; p = 0.022). Conversely, when sleep duration exceeded 7.23 h, it was positively associated with mortality (HR: 1.187; 95% CI: 1.066, 1.320; p = 0.002).
Conclusion
Sleep duration is U-shapedly associated with all-cause mortality among individuals with hyperuricemia in the United States. However sleep trouble was not associated with all-cause mortality. Maintaining optimal sleep duration helps improve the prognostic survival rates of those with hyperuricemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
- Clinical Medicine College, , Xinjiang Medical University, Urumqi, China.
- Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Emergency Medicine, Jining First People's Hospital, Shandong First Medical University, Jining, China.
- Critical Medicine Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Zitieren
APA
Dai, Y., Sun, X., Zhang, G., Cui, C., Wu, X., Aizezi, Y., & Kadier, K. (2025). Association between sleep duration, sleep trouble and all-cause mortality in individuals with hyperuricemia in the United States. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2025.1521372
Vancouver
Dai Y, Sun X, Zhang G, Cui C, Wu X, Aizezi Y, et al. Association between sleep duration, sleep trouble and all-cause mortality in individuals with hyperuricemia in the United States. Frontiers in Public Health. 2025. doi:10.3389/fpubh.2025.1521372
BibTeX
@article{Dai2025,
author = {Dai, Yuanhui and Sun, Xiangyu and Zhang, Ge and Cui, Chunying and Wu, Xiaoli and Aizezi, Yierzhati and Kadier, Kaisaierjiang},
title = {Association between sleep duration, sleep trouble and all-cause mortality in individuals with hyperuricemia in the United States},
journal = {Frontiers in Public Health},
year = {2025},
doi = {10.3389/fpubh.2025.1521372}
}
EUVIMED